XPeng (NYSE:XPEV) Upgraded to Overweight by JPMorgan Chase & Co.
JPMorgan Chase & Co. upgraded shares of XPeng (NYSE:XPEV – Free Report) from a neutral rating to an overweight rating in a report published on Thursday morning, Marketbeat.com reports. They currently have $11.50 target price on the stock, up from their prior target price of $8.00. Several other analysts have also recently issued reports on […]
More Stories
Cell MedX (OTCMKTS:CMXC) Stock Price Down 6% – Should You Sell?
Shares of Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) fell 6% on Thursday . The company traded as low...
The European Equity Fund (NYSE:EEA) Trading Down 0.5% – What’s Next?
The European Equity Fund, Inc. (NYSE:EEA – Get Free Report)’s stock price traded down 0.5% on Thursday . The stock...
FIH group (LON:FIH) Trading Up 0.4% – What’s Next?
FIH group plc (LON:FIH – Get Free Report)’s share price traded up 0.4% on Thursday . The company traded as...
Jamieson Wellness (TSE:JWEL) Stock Price Down 0.8% – Should You Sell?
Jamieson Wellness Inc. (TSE:JWEL – Get Free Report) traded down 0.8% during trading on Thursday . The stock traded as...
Omega Therapeutics Chair Resigns from Board of Directors
On January 10, 2025, Omega Therapeutics, Inc. announced in an 8-K filing with the Securities and Exchange Commission that Christian...
CRH Completes Offering of Guaranteed Notes, CRH America Finance and SMW Finance DAC Issue SecuritiesCRH public limited company, listed on the New York Stock Exchange under the ticker CRH, recently completed a notable offering of U.S. Dollar Guarantee
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...